RhumbLine Advisers’s CME Group CME Stock Holding History

RhumbLine Advisers’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$191M	Sell	646,565 -10,729	-2%	-$3.19M	0.16%	97
2025 Q4	$179M	Sell	657,294 -10,071	-2%	-$2.74M	0.15%	107
2025 Q3	$180M	Sell	667,365 -36,500	-5%	-$9.93M	0.14%	112
2025 Q2	$194M	Sell	703,865 -684	-0.1%	-$186K	0.17%	101
2025 Q1	$187M	Buy	704,549 +22,917	+3%	+$5.65M	0.17%	98
2024 Q4	$158M	Sell	681,632 -9,361	-1%	-$2.15M	0.14%	113
2024 Q3	$152M	Sell	690,993 -15,522	-2%	-$3.21M	0.14%	124
2024 Q2	$139M	Sell	706,515 -23,910	-3%	-$4.94M	0.13%	126
2024 Q1	$157M	Sell	730,425 -2,332	-0.3%	-$490K	0.15%	117
2023 Q4	$154M	Sell	732,757 -366	-0%	-$78.1K	0.16%	109
2023 Q3	$147M	Buy	733,123 +1,064	+0.1%	+$211K	0.17%	101
2023 Q2	$136M	Buy	732,059 +12,341	+2%	+$2.28M	0.15%	110
2023 Q1	$138M	Buy	719,718 +21,237	+3%	+$3.84M	0.17%	107
2022 Q4	$117M	Buy	698,481 +26,002	+4%	+$4.52M	0.16%	121
2022 Q3	$119M	Buy	672,479 +19,437	+3%	+$3.84M	0.18%	106
2022 Q2	$134M	Buy	653,042 +6,485	+1%	+$1.37M	0.2%	93
2022 Q1	$154M	Buy	646,557 +35,182	+6%	+$8.26M	0.2%	92
2021 Q4	$140M	Buy	611,375 +10,695	+2%	+$2.35M	0.17%	101
2021 Q3	$116M	Sell	600,680 -33,447	-5%	-$6.78M	0.16%	113
2021 Q2	$135M	Sell	634,127 -27,031	-4%	-$5.71M	0.18%	102
2021 Q1	$135M	Sell	661,158 -40,909	-6%	-$8.06M	0.18%	102
2020 Q4	$128M	Buy	702,067 +220	+0%	+$37.4K	0.18%	103
2020 Q3	$117M	Buy	701,847 +713	+0.1%	+$120K	0.18%	102
2020 Q2	$114M	Buy	701,134 +10,916	+2%	+$1.96M	0.19%	99
2020 Q1	$119M	Buy	690,218 +4,346	+0.6%	+$865K	0.25%	75
2019 Q4	$138M	Sell	685,872 -4,825	-0.7%	-$990K	0.23%	81
2019 Q3	$146M	Buy	690,697 +11,452	+2%	+$2.39M	0.27%	68
2019 Q2	$132M	Sell	679,245 -3,576	-0.5%	-$659K	0.25%	73
2019 Q1	$112M	Sell	682,821 -10,172	-1%	-$1.8M	0.22%	86
2018 Q4	$130M	Buy	692,993 +34,206	+5%	+$6.32M	0.28%	69
2018 Q3	$112M	Sell	658,787 -17,473	-3%	-$2.94M	0.22%	87
2018 Q2	$111M	Sell	676,260 -8,714	-1%	-$1.42M	0.22%	83
2018 Q1	$111M	Buy	684,974 +13,273	+2%	+$2.11M	0.23%	84
2017 Q4	$98.1M	Buy	671,701 +10,178	+2%	+$1.45M	0.2%	98
2017 Q3	$89.8M	Buy	661,523 +14,879	+2%	+$1.88M	0.2%	103
2017 Q2	$81M	Buy	646,644 +6,765	+1%	+$809K	0.18%	113
2017 Q1	$76M	Sell	639,879 -9,614	-1%	-$1.16M	0.18%	117
2016 Q4	$74.9M	Buy	649,493 +54,726	+9%	+$6.09M	0.19%	107
2016 Q3	$62.2M	Buy	594,767 +39,381	+7%	+$4.11M	0.17%	116
2016 Q2	$54.1M	Buy	555,386 +45,636	+9%	+$4.31M	0.16%	125
2016 Q1	$49M	Buy	509,750 +24,538	+5%	+$2.23M	0.15%	131
2015 Q4	$44M	Buy	485,212 +2,524	+0.5%	+$238K	0.14%	140
2015 Q3	$44.8M	Buy	482,688 +9,170	+2%	+$872K	0.15%	133
2015 Q2	$44.1M	Sell	473,518 -77,105	-14%	-$7.19M	0.14%	145
2015 Q1	$52.1M	Sell	550,623 -58,780	-10%	-$5.45M	0.15%	145
2014 Q4	$54M	Sell	609,403 -7,300	-1%	-$619K	0.16%	137
2014 Q3	$49.3M	Sell	616,703 -49,061	-7%	-$3.7M	0.15%	146
2014 Q2	$47.2M	Sell	665,764 -20,660	-3%	-$1.45M	0.14%	161
2014 Q1	$50.8M	Buy	686,424 +2,240	+0.3%	+$169K	0.15%	144
2013 Q4	$53.7M	Sell	684,184 -15,548	-2%	-$1.22M	0.16%	137
2013 Q3	$51.7M	Sell	699,732 -79,940	-10%	-$5.89M	0.16%	135
2013 Q2	$59.2M	Buy	+779,672	New	+$51.2M	0.19%	111

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RhumbLine Advisers's CME Position: Q1 2026 in Review

RhumbLine Advisers reduced its CME Group (CME) stake by 1.6% in Q1 2026, selling an estimated $3.19M and leaving 646,565 shares worth $191M. The position accounts for 0.16% of the portfolio, ranked #97.

RhumbLine Advisers first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $194M in Q2 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

RhumbLine Advisers held 646,565 shares of CME Group worth $191M as of Q1 2026.
RhumbLine Advisers sold 10,729 CME Group shares in Q1 2026, an estimated $3.19M.
CME Group made up 0.16% of RhumbLine Advisers's portfolio in Q1 2026, its #97 holding.
RhumbLine Advisers first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
RhumbLine Advisers's CME Group position peaked at $194M in Q2 2025.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.